564 related articles for article (PubMed ID: 10911654)
1. Assessment of the effectiveness, safety, and biocompatibility of icodextrin in automated peritoneal dialysis. The Dextrin in APD in Amsterdam (DIANA) Group.
Posthuma N; ter Wee PM; Donker AJ; Oe PL; Peers EM; Verbrugh HA
Perit Dial Int; 2000; 20 Suppl 2():S106-13. PubMed ID: 10911654
[TBL] [Abstract][Full Text] [Related]
2. Serum disaccharides and osmolality in CCPD patients using icodextrin or glucose as daytime dwell.
Posthuma N; ter Wee PM; Donker AJ; Oe PL; van Dorp W; Peers EM; Verbrugh HA
Perit Dial Int; 1997; 17(6):602-7. PubMed ID: 9655161
[TBL] [Abstract][Full Text] [Related]
3. Peritoneal defense using icodextrin or glucose for daytime dwell in CCPD patients.
Posthuma N; ter Wee P; Donker AJ; Dekker HA; Oe PL; Verbrugh HA
Perit Dial Int; 1999; 19(4):334-42. PubMed ID: 10507814
[TBL] [Abstract][Full Text] [Related]
4. Peritoneal kinetics and mesothelial markers in CCPD using icodextrin for daytime dwell for two years.
Posthuma N; Verbrugh HA; Donker AJ; van Dorp W; Dekker HA; Peers EM; Oe PL; ter Wee PM
Perit Dial Int; 2000; 20(2):174-80. PubMed ID: 10809240
[TBL] [Abstract][Full Text] [Related]
5. Peritoneal ultrafiltration and serum icodextrin concentration during dialysis with 7.5% icodextrin solution in Japanese patients.
Ota K; Akiba T; Nakao T; Nakayama M; Maeba T; Park MS; Tranaeus A; Yorioka N;
Perit Dial Int; 2003; 23(4):356-61. PubMed ID: 12968843
[TBL] [Abstract][Full Text] [Related]
6. Icodextrin use in CCPD patients during peritonitis: ultrafiltration and serum disaccharide concentrations.
Posthuma N; ter Weel PM; Donker AJ; Peers EM; Oe PL; Verbrugh HA
Nephrol Dial Transplant; 1998 Sep; 13(9):2341-4. PubMed ID: 9761519
[TBL] [Abstract][Full Text] [Related]
7. Automated peritoneal dialysis prescriptions for enhancing sodium and fluid removal: a predictive analysis of optimized, patient-specific dwell times for the day period.
Akonur A; Guest S; Sloand JA; Leypoldt JK
Perit Dial Int; 2013; 33(6):646-54. PubMed ID: 24335125
[TBL] [Abstract][Full Text] [Related]
8. [Use of icodextrin for diurnal exchange in patients undergoing automatic peritoneal dialysis. Comparison with glucose solutions].
Bajo MA; Selgas R; del Peso G; Castro MJ; Hevia C; Gil F; Costero O; Olea T; Jiménez C
Nefrologia; 2002; 22(4):348-55. PubMed ID: 12369126
[TBL] [Abstract][Full Text] [Related]
9. Icodextrin: a review of its use in peritoneal dialysis.
Frampton JE; Plosker GL
Drugs; 2003; 63(19):2079-105. PubMed ID: 12962523
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of icodextrin in peritoneal dialysis patients.
Moberly JB; Mujais S; Gehr T; Hamburger R; Sprague S; Kucharski A; Reynolds R; Ogrinc F; Martis L; Wolfson M
Kidney Int Suppl; 2002 Oct; (81):S23-33. PubMed ID: 12230479
[TBL] [Abstract][Full Text] [Related]
11. Icodextrin metabolism and alpha-amylase activity in nonuremic rats undergoing chronic peritoneal dialysis.
García-López E; Pawlaczyk K; Anderstam B; Qureshi AR; Kuzlan-Pawlaczyk M; Heimbürger O; Werynski A; Lindholm B
Perit Dial Int; 2007; 27(4):415-23. PubMed ID: 17602150
[TBL] [Abstract][Full Text] [Related]
12. Two icodextrin exchanges per day in peritoneal dialysis patients with ultrafiltration failure: one center's experience and review of the literature.
Dousdampanis P; Trigka K; Chu M; Khan S; Venturoli D; Oreopoulos DG; Bargman JM
Int Urol Nephrol; 2011 Mar; 43(1):203-9. PubMed ID: 20953705
[TBL] [Abstract][Full Text] [Related]
13. Randomized controlled trial of icodextrin versus glucose containing peritoneal dialysis fluid.
Lin A; Qian J; Li X; Yu X; Liu W; Sun Y; Chen N; Mei C;
Clin J Am Soc Nephrol; 2009 Nov; 4(11):1799-804. PubMed ID: 19808224
[TBL] [Abstract][Full Text] [Related]
14. Three-pore model predictions of 24-hour automated peritoneal dialysis therapy using bimodal solutions.
Akonur A; Leypoldt JK
Perit Dial Int; 2011; 31(5):537-44. PubMed ID: 21632445
[TBL] [Abstract][Full Text] [Related]
15. The variability in ultrafiltration achieved with icodextrin, possibly explained.
Venturoli D; Jeloka TK; Ersoy FF; Rippe B; Oreopoulos DG
Perit Dial Int; 2009; 29(4):415-21. PubMed ID: 19602607
[TBL] [Abstract][Full Text] [Related]
16. Icodextrin instead of glucose during the daytime dwell in CCPD increases ultrafiltration and 24-h dialysate creatinine clearance.
Posthuma N; ter Wee PM; Verbrugh HA; Oe PL; Peers E; Sayers J; Donker AJ
Nephrol Dial Transplant; 1997 Mar; 12(3):550-3. PubMed ID: 9075139
[TBL] [Abstract][Full Text] [Related]
17. Peritonitis occurrence in a multicenter study of icodextrin and glucose in CAPD. MIDAS Study Group. Multicenter Investigation of Icodextrin in Ambulatory Dialysis.
Gokal R; Mistry CD; Peers EM
Perit Dial Int; 1995; 15(6):226-30. PubMed ID: 7578498
[TBL] [Abstract][Full Text] [Related]
18. Superiority of icodextrin compared with 4.25% dextrose for peritoneal ultrafiltration.
Finkelstein F; Healy H; Abu-Alfa A; Ahmad S; Brown F; Gehr T; Nash K; Sorkin M; Mujais S
J Am Soc Nephrol; 2005 Feb; 16(2):546-54. PubMed ID: 15625070
[TBL] [Abstract][Full Text] [Related]
19. Icodextrin produces higher ultrafiltration in diabetic than in non-diabetic patients on continuous cyclic peritoneal dialysis.
Ahmad M; Jeloka T; Pliakogiannis T; Tapiawala S; Zhong H; Bargman JM; Oreopoulos D
Int Urol Nephrol; 2008; 40(1):219-23. PubMed ID: 17990071
[TBL] [Abstract][Full Text] [Related]
20. Icodextrin and intraperitoneal inflammation.
Moriishi M; Kawanishi H
Perit Dial Int; 2008 Jun; 28 Suppl 3():S96-S100. PubMed ID: 18552274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]